Dr John W Grudis, MD | |
280 Exempla Cir, Lafayette, CO 80026-3370 | |
(303) 338-4545 | |
Not Available |
Full Name | Dr John W Grudis |
---|---|
Gender | Male |
Speciality | Radiology - Diagnostic Radiology |
Location | 280 Exempla Cir, Lafayette, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689718462 | NPI | - | NPPES |
004859 | Other | KAISER-COMMERCIAL NUMBER | |
01189893 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 18989 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John W Grudis, MD 280 Exempla Cir, Lafayette, CO 80026-3370 Ph: (303) 338-4545 | Dr John W Grudis, MD 280 Exempla Cir, Lafayette, CO 80026-3370 Ph: (303) 338-4545 |
News Archive
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced updated survival data from a pivotal Phase II clinical trial of single-agent brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma (HL) after autologous stem cell transplant (ASCT) showing that the median overall survival has not been reached after a 26.5 month median follow-up.
Scientists at Yale University have identified a set of plasma biomarkers that could reasonably predict the risk of metastasis among patients with melanoma, according to findings published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Based on proof-of-concept results from clinical trials at University of North Carolina Lineberger Comprehensive Cancer Center and Baylor College of Medicine, an investigational cellular immunotherapy for Hodgkin lymphoma has received a Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration.
Every year, almost 10,000 Danes are admitted to hospital with blood poisoning, while more than 3,000 patients become infected while they are hospitalised. New research shows that Danes suffering from blood poisoning risk an extra challenge in the form of an increased risk of suffering a blood clot:
Fortis Healthcare, one of India's leading private hospital groups, has announced it will broaden inclusion criteria for its upcoming diabetic foot clinical trial. The study will use stem cells derived from peripheral blood to treat critical limb ischemia (diabetic foot).
› Verified 4 days ago
Dr. Lena Claire Schaffer, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1434 S Larkspur Ct, Lafayette, CO 80026 Phone: 303-440-0194 | |
Dr. Sirisha T Komakula, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Changhu Chen, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 200 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Dennis Toy, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Marc A Laberge, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Andrew Michael Knight, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 200 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |